Search
for
Sort by
Research 91–120 of 1000+
- Penile vascular abnormalities in young men with persistent side effects after finasteride use for the treatment of androgenic alopecia
- EFFICACY OF FLAXSEED CRACKERS IN AMELIORATING CLINICAL AND BIOCHEMICAL HYPERANDROGENISM IN YOUNG ADULT SOUTH INDIAN WOMEN DIAGNOSED WITH PCOS
- Biomaterials and Stem Cells: Promising Tools in Tissue Engineering and Biomedical Applications
- Standards of Care for the Health of Transsexual, Transgender, and Gender-Nonconforming People, Version 7
- The human keratins: biology and pathology
- Polycystic ovary syndrome
- Endocrine Treatment of Transsexual Persons:An Endocrine Society Clinical Practice Guideline
- Erasing the methyl mark: histone demethylases at the center of cellular differentiation and disease
- Melatonin membrane receptors in peripheral tissues: Distribution and functions
- The Neurobiology of Sexual Function
- ACOG Practice Bulletin No. 108: Polycystic Ovary Syndrome
- The Rotterdam Study: 2018 update on objectives, design and main results
- The Rotterdam Study: 2016 objectives and design update
- Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria
- Aging and Immortality: Quasi-Programmed Senescence and Its Pharmacologic Inhibition
- Transforming growth factor-β in stem cells and tissue homeostasis
- Is COVID-19 Gender-sensitive?
- Evaluation and treatment of male and female pattern hair loss
- COVID-19 and Sex Differences
- The PDGF/PDGFR pathway as a drug target
- ATP-dependent chromatin remodeling during mammalian development
- Wound Healing and the Use of Medicinal Plants
- Endocrinology of Transgender Medicine
- Extraskeletal actions of vitamin D
- Polymorphisms of the Androgen Receptor Gene and the Estrogen Receptor β Gene Are Associated with Androgen Levels in Women1
- Green tea: Health benefits
- Dermatologic Manifestations of Polycystic Ovary Syndrome
- Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome
- GWAS for male-pattern baldness identifies 71 susceptibility loci explaining 38% of the risk
- Androgens and hair loss